Compare, Analyse Abbott India with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs MYLAN (US) - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   MYLAN
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
MYLAN
Dec-18
ABBOTT INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6,1103,398-   
Low Rs3,9961,870-   
Sales per share (Unadj.) Rs1,552.21,563.6-  
Earnings per share (Unadj.) Rs188.842.5-  
Cash flow per share (Unadj.) Rs196.4335.2-  
Dividends per share (Unadj.) Rs55.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs796.61,691.6-  
Shares outstanding (eoy) m21.25514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.31.7 193.2%   
Avg P/E ratio x26.862.0 43.1%  
P/CF ratio (eoy) x25.77.9 327.4%  
Price / Book Value ratio x6.31.6 407.3%  
Dividend payout %29.10-   
Avg Mkt Cap Rs m107,3761,355,343 7.9%   
No. of employees `0003.335.0 9.5%   
Total wages/salary Rs m3,9370-   
Avg. sales/employee Rs Th9,929.322,985.5 43.2%   
Avg. wages/employee Rs Th1,185.10-   
Avg. net profit/employee Rs Th1,207.7624.2 193.5%   
INCOME DATA
Net Sales Rs m32,985804,494 4.1%  
Other income Rs m1,1700-   
Total revenues Rs m34,155804,494 4.2%   
Gross profit Rs m5,245208,173 2.5%  
Depreciation Rs m162150,633 0.1%   
Interest Rs m3838,693 0.1%   
Profit before tax Rs m6,21518,847 33.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203-2,998 -73.5%   
Profit after tax Rs m4,01221,845 18.4%  
Gross profit margin %15.925.9 61.5%  
Effective tax rate %35.4-15.9 -222.8%   
Net profit margin %12.22.7 447.9%  
BALANCE SHEET DATA
Current assets Rs m22,655449,229 5.0%   
Current liabilities Rs m6,681327,537 2.0%   
Net working cap to sales %48.415.1 320.2%  
Current ratio x3.41.4 247.2%  
Inventory Days Days6584 77.5%  
Debtors Days Days2993 31.2%  
Net fixed assets Rs m835156,059 0.5%   
Share capital Rs m213428 49.6%   
"Free" reserves Rs m16,7150-   
Net worth Rs m16,928870,315 1.9%   
Long term debt Rs m0939,350 0.0%   
Total assets Rs m24,1622,334,524 1.0%  
Interest coverage x163.71.5 11,007.5%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.40.3 396.2%   
Return on assets %16.82.6 646.4%  
Return on equity %23.72.5 944.3%  
Return on capital %36.93.2 1,161.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,4380-   
CASH FLOW
From Operations Rs m1,527167,174 0.9%  
From Investments Rs m-2,148-86,410 2.5%  
From Financial Activity Rs m-1,024-77,879 1.3%  
Net Cashflow Rs m-1,6461,385 -118.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare ABBOTT INDIA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ABBOTT INDIA With: WYETH LTD  SHASUN PHARMA  NATCO PHARMA  TORRENT PHARMA  ALEMBIC LTD  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Oct 17, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - STRIDES PHARMA SCIENCE COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS